A practical framework for turning patient-reported outcomes into scalable survivorship support, not another clinical inbox.
For years, cancer programs have collected information about patients: diagnoses, treatments, laboratory results, imaging, utilization, and clinical outcomes. Increasingly, health systems are being asked to systematically collect information from patients themselves.
Electronic patient-reported outcomes, or ePROs, capture symptoms, functioning, quality of life, and other aspects of a patient’s experience directly and digitally. Their growing role in oncology is visible at the federal level. CMS’s Enhancing Oncology Model requires participating practices to collect and monitor ePROs as one of eight core care redesign activities. The model also links electronic patient reporting with navigation, comprehensive care planning, social-needs screening, and continuous quality improvement.
Survivorship is moving in the same direction. The National Cancer Institute’s National Standards for Cancer Survivorship Care call for health systems to collect longitudinal patient-reported outcomes and survivors’ experiences of care, while assessing physical and psychological effects at multiple points in follow-up.
For health-system leaders, however, collecting another survey is the easy part. The harder question is: What happens after the patient presses “submit”?
The most effective ePRO strategy is not simply a measurement program. It is a care-delivery workflow in which a small set of meaningful patient-reported signals can trigger the right education, intervention, referral, or clinical escalation while allowing most routine responses to be managed without adding substantial staff workload.
Why ePROs Matter Beyond Active Cancer Treatment
Much of the strongest evidence for electronic symptom monitoring comes from active oncology treatment, where patients may report symptoms between appointments and care teams can intervene before problems worsen.
That infrastructure is increasingly being implemented at scale. Through its Health Systems Implementation Initiative, PCORI is supporting health systems in deploying electronic symptom monitoring across real-world oncology environments. For example, Duke University Health System’s current project spans 47 sites and is designed to reach more than 7,000 adults with metastatic cancer. Importantly, its implementation metrics include not only whether patients complete surveys, but also whether clinicians follow up on symptom alerts and whether the program can be sustained.
The same logic becomes particularly relevant during survivorship. After treatment, visits often become less frequent while symptoms can remain persistent or emerge months later. Fatigue, pain, sleep disturbance, anxiety, neuropathy, functional limitations, sexual-health concerns, and fear of recurrence do not necessarily align with scheduled oncology appointments.
NCI’s survivorship standards therefore recommend assessing survivors repeatedly for physical, emotional, psychological, practical, and social effects rather than treating survivorship assessment as a one-time event. They also recommend longitudinal collection of patient-reported outcomes, quality of life, and patient experience. ePROs offer a practical way to create those additional touchpoints without converting each one into a clinical visit.
The Biggest ePRO Mistake: Collecting Data Without a Response Pathway
A health system can technically have an ePRO program while still gaining very little from it.
Imagine that survivors receive a 25-question quality-of-life assessment every three months. Responses appear somewhere in the EHR, but no one has clear responsibility for reviewing them. A patient reports worsening fatigue and severe anxiety. The scores are stored successfully.
Nothing happens. The organization has collected data, but it has not delivered care.
The operational objective should therefore be defined before the first questionnaire is deployed. Every measure should have a reason for being collected and, where appropriate, a predefined response.
For example:
A significant increase in fatigue might trigger evidence-based self-management resources first, followed by rehabilitation or clinical assessment if severity or functional impact crosses a defined threshold.
Elevated psychological distress might route a survivor toward behavioral-health resources, a structured intervention, peer support, or urgent clinical assessment depending on severity.
A decline in physical function could trigger exercise or rehabilitation programming before requiring a specialist appointment for every patient.
The principle is simple: do not collect a patient-reported signal unless the program knows what it intends to do with it.
Start With a Small Measurement Set, Not a Giant Questionnaire
One of the quickest ways to undermine an ePRO program is to collect too much information too often.
A survivorship program does not need to measure every possible symptom at every interaction. Instead, leaders can select a small number of domains that correspond to services the organization can actually provide or coordinate.
A practical starting set might include:
overall quality of life or health status;
fatigue;
pain;
emotional distress;
physical function; and
one or two needs relevant to the program’s patient population.
Different tumor types or treatment exposures can then trigger additional modules.
Validated measures should be used when clinical interpretation or longitudinal comparison matters. NCI’s PRO-CTCAE system, for example, was designed to capture symptomatic toxicities directly from patients and includes measures of symptom frequency, severity, interference, and presence. NCI notes that patient reporting can capture symptoms that may be missed when information is filtered through clinicians or restricted to clinic encounters.
Not every survivorship program needs to use PRO-CTCAE specifically; the appropriate instrument depends on the purpose of measurement. The larger principle is to choose tools intentionally and avoid creating survey burden simply because more data can be collected.
Build Tiered Responses Instead of Sending Every Alert to a Nurse
The fear that stops many organizations from expanding remote monitoring is understandable: Will this generate hundreds of alerts that staff have to manage? It can, if the workflow is poorly designed.
A scalable ePRO pathway should separate routine needs from concerns requiring professional attention.
For lower-severity responses, the platform may automatically provide education, guided exercises, symptom-management content, group programming, or another low-intensity intervention.
Moderate or persistent symptoms can be routed to the appropriate supportive-care pathway—for example rehabilitation, behavioral health, nutrition, pelvic health, or a survivorship navigator.
Only high-risk responses or defined red flags should require immediate clinical review.
The thresholds should be created with clinical leadership and aligned with the organization’s scope, services, and escalation policies. Technology can execute the routing logic, but it should not independently determine diagnosis or replace professional judgment.
This model lets clinicians work by exception rather than manually reviewing every normal or low-risk response.
Reassessment Is What Turns ePROs Into a Care Loop
A referral or digital intervention should not be the end of the workflow.
Suppose a survivor reports severe insomnia. The system identifies the issue and connects that person with an evidence-based sleep intervention. Four weeks later, what happened? Did the survivor participate? Did sleep improve? Is the problem unchanged? Has anxiety worsened? Does the patient now require individual behavioral-health or medical evaluation?
That second measurement is where ePROs become particularly useful. The same outcome can be reassessed after an intervention, giving both the survivor and the program visibility into progress.
Recent research offers an example of this model in survivorship. A 2026 feasibility trial involving 200 breast and gynecologic cancer survivors used ePRO triggers to connect participants with nurse and dietitian consultations. More than 70% of participants in the experimental group engaged with consultations after an ePRO trigger, and the intervention met its predefined feasibility endpoints. The study also reported improvements in fatigue, anxiety, depression, and quality of life, although the authors appropriately concluded that a larger powered efficacy trial is still needed.
The important implementation lesson is not that ePROs themselves treat symptoms. It is that patient-reported data becomes useful when it activates a defined support pathway and is followed by reassessment.
Design the Workflow Around Five Questions
Before launching or expanding an ePRO survivorship program, health-system leaders should be able to answer five questions.
What are we measuring?Choose a focused set of outcomes linked to survivorship priorities and available interventions.
When will we measure it?Potential touchpoints include transition from treatment, three- or six-month intervals, annual survivorship follow-up, after specific interventions, and after major clinical changes.
What score triggers action?Define normal, moderate, and high-risk pathways with clinical leadership rather than making every response equally urgent.
Who owns the response?Each trigger needs a destination. That may be automated education, a navigator, a supportive-care service, primary care, or oncology.
How will we know what happened next?Track whether the survivor engaged with the intervention, whether referral was completed, and whether the relevant outcome changed.
Without answers to these five questions, an ePRO system risks becoming another data repository.
Measure Program Performance, Not Just Survey Completion
Completion rate matters, but it is only the beginning.
A useful survivorship dashboard can show:
percentage of eligible survivors offered ePRO monitoring;
enrollment and ongoing completion;
prevalence of identified needs;
frequency and type of automated interventions;
number of supportive-care referrals;
referral completion;
clinical escalations;
changes in selected patient-reported outcomes;
functional outcomes;
patient experience; and
differences in participation or outcomes across patient populations.
This closely matches the direction of NCI’s survivorship standards, which call for health systems to measure patient-reported outcomes, functional capacity, return to productive activities, loss to follow-up, caregiver needs, referral completion, utilization, and other relevant business measures.
The objective is not to create a research registry. It is to understand whether the survivorship program is reaching patients and whether the services being offered are producing meaningful engagement and improvement.
ePRO Infrastructure Can Bridge Oncology and Survivorship
CMS’s Enhancing Oncology Model is focused on defined episodes of systemic cancer treatment; it is not itself a survivorship-care standard. But its inclusion of ePRO collection, monitoring, navigation, care planning, and continuous quality improvement reflects a broader shift toward longitudinal, patient-centered oncology data.
Health systems that establish these workflows during active treatment have an opportunity to avoid turning them off when treatment ends.
Instead, the same infrastructure can transition with the patient.
Survey frequency can decrease. The domains being measured can shift from acute toxicity toward long-term symptoms, quality of life, function, emotional well-being, and practical needs. Escalation pathways can move from treatment toxicity management toward rehabilitation, behavioral health, primary care, lifestyle support, and other survivorship services.
That creates continuity rather than another handoff.
Where The After Cancer Fits
The After Cancer is designed to help health systems deliver continuous survivorship support outside the boundaries of clinic visits. The platform combines personalized survivorship programming with symptom tracking, educational resources, group support, asynchronous guidance, and actionable reporting, while allowing organizations to align pathways with their own clinical workflow and services. The company’s health-system model is specifically positioned around extending survivorship care without requiring additional FTEs.
In an ePRO-enabled model, the value is not simply collecting another patient questionnaire. It is connecting information to action: using reported needs to personalize resources, guide participation, surface higher-risk concerns, support referral pathways, and measure changes over time.
Clinical governance remains with the health system. The digital layer helps make routine monitoring and support more scalable.
The Future of Survivorship Measurement Is Actionable, Not Passive
Patient-reported outcomes are moving closer to the center of oncology quality and care delivery.
The next step is ensuring that survivorship programs do not recreate the familiar problem of collecting more data than clinical teams can use.
A well-designed ePRO program should be deliberately small, longitudinal, automated where appropriate, and connected to defined care pathways. Most importantly, it should answer a question that matters to both the patient and the health system:
When a survivor tells us something has changed, what are we going to do about it?
Health systems that can answer that question reliably will be better positioned to turn survivorship measurement into meaningful, scalable care.
If your organization is exploring how to build longitudinal symptom monitoring and personalized survivorship pathways without creating another manual workflow, book a conversation with The After Cancer to discuss how a digital survivorship layer could complement your existing services.